{"DataElement":{"publicId":"2897705","version":"2","preferredName":"Specimen Granulocyte Infiltration Percentage Value","preferredDefinition":"Numeric value to represent the percentage of infiltration by granulocytes in a tumor sample or specimen.","longName":"SPEC_GRAN_PRG_VAL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2897703","version":"1","preferredName":"Specimen Granulocyte Infiltration","preferredDefinition":"A flat rectangular piece of glass on which specimens can be mounted for microscopic study._A leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils.:The process of the diffusion or accumulation in a tissue or cells of a substance not normal to it or in amounts above normal. (NCI):A fraction or ratio with 100 understood as the denominator._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The diffusion or accumulation in a tissue or cells of substances not normal to it or in amounts above normal.","longName":"SPEC_GRAN_INFIL","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2241613","version":"1","preferredName":"Specimen","preferredDefinition":"Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2242-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2897701","version":"1","preferredName":"Granulocyte Infiltration","preferredDefinition":"A leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils. (from On-line Medical Dictionary):The diffusion or accumulation in a tissue or cells of substances not normal to it or in amounts above normal.","longName":"C12530:C25754","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granulocyte","conceptCode":"C12530","definition":"A type of leukocyte with a multilobed nucleus and cytoplasmic granules. The unique morphology of the nucleus has led to their also being known as polymorphonuclear leukocytes (PMLs or PMNs). Granulocytes are subdivided according to the staining properties of their granules into eosinophils (red with acidic dye), basophils (blue with basic dye), and neutrophils (not amenable to staining with either acidic or basic dyes).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infiltration","conceptCode":"C25754","definition":"The process of the diffusion or accumulation in a tissue or cells of a substance not normal to it or in amounts above normal. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B7700FF-FC74-B3ED-E040-BB89AD431469","latestVersionIndicator":"Yes","beginDate":"2009-06-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-03","modifiedBy":"ONEDATA","dateModified":"2009-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B7700FF-FC85-B3ED-E040-BB89AD431469","latestVersionIndicator":"Yes","beginDate":"2009-06-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180234","version":"1.1","preferredName":"Lab Percentage Value","preferredDefinition":"the value as a percentage of 100.","longName":"LAB_PTG_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2954D9F1-B403-0D97-E050-BB89AD435FCC","latestVersionIndicator":"Yes","beginDate":"2004-01-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-14","modifiedBy":"REEVESD","dateModified":"2016-11-23","changeDescription":"v1.1 of VD replaces v1.0 to increase overall field length and include 2 decimal places. 1.14.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5428053","version":"1","longName":"Biospecimen","context":"GDC","ClassificationSchemeItems":[{"publicId":"5428324","version":"1","longName":"Slide","context":"GDC"}]}],"AlternateNames":[{"name":"percent_granulocyte_infiltration","type":"GDC_Name","context":"GDC"}],"ReferenceDocuments":[{"name":"% Granulocytes","type":"Preferred Question Text","description":"% Granulocytes","url":null,"context":"NCIP"},{"name":"GDC Question Text","type":"Alternate Question Text","description":"Percent Granulocyte Infiltration","url":null,"context":"GDC"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C1492F2-B594-55C3-E050-BB89AD433A2A","latestVersionIndicator":"Yes","beginDate":"2016-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-09-09","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":"Versioned to extend VD max length, add decimal, and remove tumor term from definition. mc 9/9/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}